Seed VC · Italy
Claris Ventures
What they invest in
Claris Ventures makes equity investments in early stage biopharma companies with a clear vision and solid scientific evidence, committed to helping the best innovators address strong unmet clinical needs spanning rare diseases, oncology, immunology and other life-threatening disease areas.
Who they back
Business models
biotech_therapeutics
Customer segments
Researchers, Healthcare providers
Geography
Europe
Recent investments
- NeoPhore
- Resalis Therapeutics
- IAMA Therapeutics
+ 3 more deals. Score your deck to see the full investment history.
The people who write checks
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
Why this firm matters for fundraising founders
Claris Ventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Claris Ventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
At a glance
- Based in
- Italy
- Last known deal
- Jul 2021
- Portfolio last checked
- Oct 15, 2026
- Website
- www.clarisventures.com ↗
Other firms investing in DeepTech
See all investorsSeed VC
Atinum Investment
DeepTech, AI, Industry 4.0 / Robotics
Seed VC
Atlantic Bridge
DeepTech, AI, Electronics
Seed VC
Atlantic Labs
DeepTech, AI, Industry 4.0 / Robotics
Seed VC
Atlas Ventures
DeepTech, Healthtech, Biotech
Seed VC
Atmosclear
DeepTech, Energy, Cleantech
Seed VC
Atomico
DeepTech, Aerospace, Industry 4.0 / Robotics
Is Claris Ventures the right fit for your deck?
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Claris Ventures is one of them, and we'll tell you exactly where they sit in your top 100.